\-\ Texto\\:\\ \ \(0\)\
\-\ moderate\\ point\\ tenderness\\ over\\ the\\ head\\ of\\ the\\ left\\ second\\ metatarsal\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ freiberg\\'s\\ infraction\\ vary\\ based\\ upon\\ the\\ level\\ of\\ collapse\\ and\\ include\\ support\\ with\\ padding\\ or\\ orthotics\\,\\ casting\\ \\(used\\ in\\ the\\ early\\ stages\\ to\\ decrease\\ the\\ tendency\\ of\\ the\\ distal\\ bone\\ to\\ collapse\\)\\,\\ and\\ steroid\\ injections\\.\ \(0\)\
\-\ this\\ patient\\ was\\ under\\ treatment\\ with\\ conservative\\ measures\\ as\\ of\\ this\\ writing\\.\ \(0\)\
\-\ three\\ views\\ of\\ the\\ left\\ foot\\ demonstrate\\ flattening\\ of\\ the\\ second\\ metatarsal\\ head\\ with\\ associated\\ subchondral\\ lucency\\ and\\ subchondral\\ sclerosis\\.\\ \\ the\\ remaining\\ bones\\,\\ joints\\,\\ and\\ soft\\ tissues\\ are\\ unremarkable\\.\ \(0\)\
\-\ freiberg\\'s\\ infraction\ \(1\)\
\-\ essentially\\ pathognomonic\\ findings\\ for\\ freiberg\\'s\\ infraction\\.\ \(0\)\
\-\ this\\ patient\\ is\\ a\\ 14\\-year\\-old\\ female\\ soccer\\ player\\ and\\ track\\ athlete\\ who\\ presents\\ with\\ a\\ 3\\ month\\ history\\ of\\ left\\ foot\\ pain\\,\\ especially\\ over\\ the\\ dorsal\\ and\\ plantar\\ surfaces\\ of\\ the\\ distal\\ aspects\\ of\\ the\\ first\\ through\\ third\\ metatarsals\\.\ \(0\)\
\-\ please\\ see\\ the\\ accompanying\\ factoid\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ freiberg\\:\\ 0\\.3625592919863452\ \(0\)\
\-\ infraction\\:\\ 0\\.3625592919863452\ \(0\)\
\-\ the\\:\\ 0\\.23801921368245169\ \(0\)\
\-\ metatarsal\\:\\ 0\\.18249317610688062\ \(0\)\
\-\ subchondral\\:\\ 0\\.17562220292940087\ \(0\)\
\-\ collapse\\:\\ 0\\.17210911119662928\ \(0\)\
\-\ of\\:\\ 0\\.16161080873937506\ \(0\)\
\-\ foot\\:\\ 0\\.1450092425174035\ \(0\)\
\-\ padding\\:\\ 0\\.1402198296090389\ \(0\)\
\-\ second\\:\\ 0\\.1373875294192929\ \(0\)\
\-\ orthotics\\:\\ 0\\.12907007952457983\ \(0\)\
\-\ writing\\:\\ 0\\.1225478938327587\ \(0\)\
\-\ tendency\\:\\ 0\\.11792032944012074\ \(0\)\
\-\ athlete\\:\\ 0\\.11544070952154162\ \(0\)\
\-\ and\\:\\ 0\\.1137647772182523\ \(0\)\
\-\ player\\:\\ 0\\.11139814374829962\ \(0\)\
\-\ metatarsals\\:\\ 0\\.11139814374829962\ \(0\)\
\-\ soccer\\:\\ 0\\.10970334724432264\ \(0\)\
\-\ head\\:\\ 0\\.1094537163967706\ \(0\)\
\-\ distal\\:\\ 0\\.1066280812897852\ \(0\)\
\-\ surfaces\\:\\ 0\\.10487595805647852\ \(0\)\
\-\ vary\\:\\ 0\\.10318116155250152\ \(0\)\
\-\ track\\:\\ 0\\.10214301496302368\ \(0\)\
\-\ accompanying\\:\\ 0\\.10214301496302368\ \(0\)\
\-\ over\\:\\ 0\\.10204365786673249\ \(0\)\
\-\ injections\\:\\ 0\\.10116782614140568\ \(0\)\
\-\ stages\\:\\ 0\\.09815639946933469\ \(0\)\
\-\ casting\\:\\ 0\\.0970204672343193\ \(0\)\
\-\ aspects\\:\\ 0\\.09496417935670344\ \(0\)\
\-\ this\\:\\ 0\\.09458974668301617\ \(0\)\
\-\ left\\:\\ 0\\.0939026034601885\ \(0\)\
\-\ plantar\\:\\ 0\\.09372620797201944\ \(0\)\
\-\ essentially\\:\\ 0\\.09285649945724522\ \(0\)\
\-\ flattening\\:\\ 0\\.09049828154249819\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.09025638692167622\ \(0\)\
\-\ support\\:\\ 0\\.08909864357938146\ \(0\)\
\-\ steroid\\:\\ 0\\.08844199366488233\ \(0\)\
\-\ treatment\\:\\ 0\\.08741900272923694\ \(0\)\
\-\ remaining\\:\\ 0\\.08720402228019833\ \(0\)\
\-\ dorsal\\:\\ 0\\.08463951726144713\ \(0\)\
\-\ options\\:\\ 0\\.08272609328431478\ \(0\)\
\-\ lucency\\:\\ 0\\.07898704008440025\ \(0\)\
\-\ decrease\\:\\ 0\\.07886832597248751\ \(0\)\
\-\ joints\\:\\ 0\\.07886832597248751\ \(0\)\
\-\ please\\:\\ 0\\.07697370467330437\ \(0\)\
\-\ under\\:\\ 0\\.0759552830270143\ \(0\)\
\-\ point\\:\\ 0\\.07585689930041652\ \(0\)\
\-\ measures\\:\\ 0\\.07481262366184413\ \(0\)\
\-\ bones\\:\\ 0\\.07383202879441687\ \(0\)\
\-\ especially\\:\\ 0\\.07258445114539602\ \(0\)\
\-\ views\\:\\ 0\\.07242518559527644\ \(0\)\
\-\ tissues\\:\\ 0\\.0723461402806664\ \(0\)\
\-\ upon\\:\\ 0\\.07218920548316321\ \(0\)\
\-\ with\\:\\ 0\\.07186994273737204\ \(0\)\
\-\ conservative\\:\\ 0\\.07084170918370528\ \(0\)\
\-\ third\\:\\ 0\\.06986652036208728\ \(0\)\
\-\ moderate\\:\\ 0\\.0688833821016349\ \(0\)\
\-\ used\\:\\ 0\\.06869376470964644\ \(0\)\
\-\ based\\:\\ 0\\.06646746796594302\ \(0\)\
\-\ early\\:\\ 0\\.06614249349596416\ \(0\)\
\-\ sclerosis\\:\\ 0\\.06535767008136202\ \(0\)\
\-\ factoid\\:\\ 0\\.06408191667307453\ \(0\)\
\-\ first\\:\\ 0\\.06192218349262215\ \(0\)\
\-\ three\\:\\ 0\\.06159555929297115\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0615149291033262\ \(0\)\
\-\ patient\\:\\ 0\\.059688947843172684\ \(0\)\
\-\ tenderness\\:\\ 0\\.05754401462518735\ \(0\)\
\-\ see\\:\\ 0\\.05707952549570182\ \(0\)\
\-\ month\\:\\ 0\\.055817831400707854\ \(0\)\
\-\ for\\:\\ 0\\.05562266928645147\ \(0\)\
\-\ level\\:\\ 0\\.055427518233782475\ \(0\)\
\-\ through\\:\\ 0\\.0546217226008849\ \(0\)\
\-\ include\\:\\ 0\\.054595545720976205\ \(0\)\
\-\ who\\:\\ 0\\.05190434220915197\ \(0\)\
\-\ bone\\:\\ 0\\.050066365054936016\ \(0\)\
\-\ soft\\:\\ 0\\.0488503386793228\ \(0\)\
\-\ associated\\:\\ 0\\.048363675670941\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04770276521101793\ \(0\)\
\-\ to\\:\\ 0\\.04587895139634746\ \(0\)\
\-\ findings\\:\\ 0\\.045286561283294446\ \(0\)\
\-\ female\\:\\ 0\\.04427776814932339\ \(0\)\
\-\ presents\\:\\ 0\\.044140634418903396\ \(0\)\
\-\ as\\:\\ 0\\.03686269571227105\ \(0\)\
\-\ history\\:\\ 0\\.035057106249216416\ \(0\)\
\-\ are\\:\\ 0\\.034818224559064394\ \(0\)\
\-\ pain\\:\\ 0\\.03283461241876309\ \(0\)\
\-\ was\\:\\ 0\\.03197878883290797\ \(0\)\
\-\ or\\:\\ 0\\.03192119131666999\ \(0\)\
\-\ is\\:\\ 0\\.025128722525083066\ \(0\)\
\-\ in\\:\\ 0\\.022826567646296606\ \(0\)\
